-
1
-
-
0027424828
-
Molecular determinant of insulin action
-
Kahn CR, Folli F (1993) Molecular determinant of insulin action. Hormon Res 39:93-101
-
(1993)
Hormon Res
, vol.39
, pp. 93-101
-
-
Kahn, C.R.1
Folli, F.2
-
2
-
-
0024160877
-
Banting lecture 1988: Role of insulin resistance in human disease
-
Reaven GM (1988) Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607
-
(1988)
Diabetes
, vol.37
, pp. 1595-1607
-
-
Reaven, G.M.1
-
3
-
-
67650234495
-
Insulin resistance, hyperinsulinemia and cancer risk
-
Chapter 2. Nova Science Publishers Inc, New York
-
Suba Zs (2009) Insulin resistance, hyperinsulinemia and cancer risk. Chapter 2, pp 19-40. In: Estrogen versus Cancer. Nova Science Publishers Inc, New York
-
(2009)
Estrogen Versus Cancer
, pp. 19-40
-
-
Suba, Zs.1
-
4
-
-
15444368857
-
Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes
-
Björnström L, Sjöberg M (2005) Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 19:833-842
-
(2005)
Mol Endocrinol
, vol.19
, pp. 833-842
-
-
Björnström, L.1
Sjöberg, M.2
-
5
-
-
13144256679
-
Sex steroids, cardiovascular disease, and hypertension
-
Reckelhoff JF (2005) Sex steroids, cardiovascular disease, and hypertension. Hypertension 45:170-174
-
(2005)
Hypertension
, vol.45
, pp. 170-174
-
-
Reckelhoff, J.F.1
-
6
-
-
84867507628
-
Insulin resistance, estrogen deficiency and cancer risk
-
Chapter 7. Nova Science Publishers Inc. New York
-
Suba Zs (2009) Insulin resistance, estrogen deficiency and cancer risk. Chapter 7 In: Estrogen versus Cancer. Nova Science Publishers Inc. New York
-
(2009)
Estrogen Versus Cancer
-
-
Suba, Zs.1
-
7
-
-
0344286476
-
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
-
Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141-146
-
(1999)
Diabetes Care
, vol.22
, pp. 141-146
-
-
Ehrmann, D.A.1
Barnes, R.B.2
Rosenfield, R.L.3
Cavaghan, M.K.4
Imperial, J.5
-
10
-
-
0035146518
-
The impact of years since menopause on the development of impaired glucose tolerance
-
Wu ShI, Chou P, Tsai ShT (2001) The impact of years since menopause on the development of impaired glucose tolerance. J Clin Epidemiol 54:117-120
-
(2001)
J Clin Epidemiol
, vol.54
, pp. 117-120
-
-
Shi, W.1
Chou, P.2
Sht, T.3
-
11
-
-
0031790832
-
Insulin stimulates testosterone biosynthesis by human thecal cells from women polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system
-
Nestler JE, Jakubowicz DJ, DdeVargas AF, Brik C, Quintero N, Medina F (1998) Insulin stimulates testosterone biosynthesis by human thecal cells from women polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83:2001-2005
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 2001-2005
-
-
Nestler, J.E.1
Jakubowicz, D.J.2
Ddevargas, A.F.3
Brik, C.4
Quintero, N.5
Medina, F.6
-
12
-
-
0026021161
-
Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease
-
DeFronzo RA, Ferrannini E (1991) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194
-
(1991)
Diabetes Care
, vol.14
, pp. 173-194
-
-
Defronzo, R.A.1
Ferrannini, E.2
-
13
-
-
21544449740
-
Second World Congress on the Insulin Resistance Syndrome: Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy
-
Bloomgarden ZT (2005) Second World Congress on the Insulin Resistance Syndrome: mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy. Diabetes Care 28:1821-1830
-
(2005)
Diabetes Care
, vol.28
, pp. 1821-1830
-
-
Bloomgarden, Z.T.1
-
14
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
-
Wrighting Group for the Women's Health Initiative Investigators
-
Wrighting Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
-
15
-
-
36849096092
-
Gender-related hormonal risk factors for oral cancer
-
Suba Z (2007) Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res 13:195-202
-
(2007)
Pathol Oncol Res
, vol.13
, pp. 195-202
-
-
Suba, Z.1
-
16
-
-
77954564373
-
Common soil of smoking-associated and hormone-related cancers: Estrogen deficiency
-
Suba Z (2010) Common soil of smoking-associated and hormone-related cancers: estrogen deficiency. Oncol Rev 4:73-87
-
(2010)
Oncol Rev
, vol.4
, pp. 73-87
-
-
Suba, Z.1
-
17
-
-
79958028665
-
Dual estrogen effects on breast cancer: Endogenous estrogen stimulates, exogenous estrogen protects. Further investigation of estrogen chemoprevention is warranted
-
Ragaz J, Wilson K, Frohlich J, Muraca G, Budlovsky J (2010) Dual estrogen effects on breast cancer: endogenous estrogen stimulates, exogenous estrogen protects. Further investigation of estrogen chemoprevention is warranted. Cancer Res 70(suppl 24):441
-
(2010)
Cancer Res
, vol.70
, Issue.SUPPL. 24
, pp. 441
-
-
Ragaz, J.1
Wilson, K.2
Frohlich, J.3
Muraca, G.4
Budlovsky, J.5
-
19
-
-
0034692430
-
Role of insulin-like growth factor family in cancer development and progression
-
Yu H, Rohan Th (2000) Role of insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92:1472-1489
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 1472-1489
-
-
Yu, H.1
Rohan, Th.2
-
20
-
-
0036845537
-
Fasting glucose is a risk factor for breast cancer
-
Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F (2002) Fasting glucose is a risk factor for breast cancer. Cancer Epidemiol Biomark & Prev 11:1361-1368
-
(2002)
Cancer Epidemiol Biomark & Prev
, vol.11
, pp. 1361-1368
-
-
Muti, P.1
Quattrin, T.2
Grant, B.J.3
Krogh, V.4
Micheli, A.5
Schunemann, H.J.6
Ram, M.7
Freudenheim, J.L.8
Sieri, S.9
Trevisan, M.10
Berrino, F.11
-
21
-
-
0035346964
-
HS: Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: The Paris Prospective Study
-
Balkau B, Kahn H (2001) HS: Hyperinsulinemia predicts fatal liver cancer but is inversely associated with fatal cancer at some other sites: The Paris Prospective Study. Diabetes Care 24:843-849
-
(2001)
Diabetes Care
, vol.24
, pp. 843-849
-
-
Balkau, B.1
Kahn, H.2
-
22
-
-
0028113617
-
Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk?
-
McKeown-Eyssen (1994) Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomark and Prev 3:687-695
-
(1994)
Cancer Epidemiol Biomark and Prev
, vol.3
, pp. 687-695
-
-
McKeown-Eyssen1
-
23
-
-
0038246527
-
Diabetes mellitus and bladder cancer. An epidemiological relationship?
-
Yeung NG, Husain I, Waterfall N (2003) Diabetes mellitus and bladder cancer. An epidemiological relationship? Pathol Oncol Res 9:30-31
-
(2003)
Pathol Oncol Res
, vol.9
, pp. 30-31
-
-
Yeung, N.G.1
Husain, I.2
Waterfall, N.3
-
24
-
-
0036852701
-
Prostate cancer: Another aspect of the insulin-resistance syndrome?
-
Barnard RJ, Aronson WJ, Tymchuk CN, Ngo TH (2002) Prostate cancer: another aspect of the insulin-resistance syndrome? Obes Rev 3:303-308
-
(2002)
Obes Rev
, vol.3
, pp. 303-308
-
-
Barnard, R.J.1
Aronson, W.J.2
Tymchuk, C.N.3
Ngo, T.H.4
-
25
-
-
1442299808
-
Diabetes and oral tumors in Hungary. Epidemiological correlations
-
Ujpál M, Matos O, Bibók Gy, Somogyi A, Szabó Gy, Suba Z (2004) Diabetes and oral tumors in Hungary. Epidemiological correlations. Diabetes Care 27:770-774
-
(2004)
Diabetes Care
, vol.27
, pp. 770-774
-
-
Ujpál, M.1
Matos, O.2
Bibók, Gy.3
Somogyi, A.4
Szabó, Gy.5
Suba, Z.6
-
26
-
-
11844286254
-
Increased prevalence of diabetes and obesity in patients with salivary gland tumors
-
Suba Z, Barabás J, Szabó Gy, Takács D, Ujpál M (2005) Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care 28:228
-
(2005)
Diabetes Care
, vol.28
, pp. 228
-
-
Suba, Z.1
Barabás, J.2
Szabó, Gy.3
Takács, D.4
Ujpál, M.5
-
27
-
-
0042412430
-
Body mass index, serum sex hormones and breast cancer risk in postmenopausal women
-
Key TJ, Applyby PN, Reeves GK (2003) Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95:1218-1226
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1218-1226
-
-
Key, T.J.1
Applyby, P.N.2
Reeves, G.K.3
-
28
-
-
13944263263
-
Risk factors for young premenopausal women with endometrial cancer
-
Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH (2005) Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 105:575-580
-
(2005)
Obstet Gynecol
, vol.105
, pp. 575-580
-
-
Soliman, P.T.1
Oh, J.C.2
Schmeler, K.M.3
Sun, C.C.4
Slomovitz, B.M.5
Gershenson, D.M.6
Burke, T.W.7
Lu, K.H.8
-
29
-
-
33947653911
-
The metabolic syndrome: A highrisk state for cancer?
-
Cowey S, Hardy RW (2006) The metabolic syndrome: a highrisk state for cancer? Am J Pathol 169:1505-1522
-
(2006)
Am J Pathol
, vol.169
, pp. 1505-1522
-
-
Cowey, S.1
Hardy, R.W.2
-
30
-
-
50549123220
-
On the treatment of inoperable cases of carcinoma of the mamma. Suggestion for a new treatment with illustrative cases
-
Beatson TG (1896) On the treatment of inoperable cases of carcinoma of the mamma. Suggestion for a new treatment with illustrative cases. Lancet 2:104-107
-
(1896)
Lancet
, vol.2
, pp. 104-107
-
-
Beatson, T.G.1
-
31
-
-
0029862593
-
Serum sex hormone levels after menopause and subsequent breast cancer
-
Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Scijano R et al (1996) Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88:291-296
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 291-296
-
-
Berrino, F.1
Muti, P.2
Micheli, A.3
Bolelli, G.4
Krogh, V.5
Scijano, R.6
-
32
-
-
0035949162
-
Menopause, hormone replacement therapy and cancer
-
La Vecchia C, Brinton LA, McTiernan A (2001) Menopause, hormone replacement therapy and cancer. Maturitas 39:97-115
-
(2001)
Maturitas
, vol.39
, pp. 97-115
-
-
La Vecchia, C.1
Brinton, L.A.2
McTiernan, A.3
-
34
-
-
0029056755
-
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women
-
Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ et al (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332:1589-1593
-
(1995)
N Engl J Med
, vol.332
, pp. 1589-1593
-
-
Colditz, G.A.1
Hankinson, S.E.2
Hunter, D.J.3
Willett, W.C.4
Manson, J.E.5
Stampfer, M.J.6
-
35
-
-
1242272127
-
Hormone replacement therapy and risk of malignancy
-
Diamanti-Kandarakis E (2004) Hormone replacement therapy and risk of malignancy. Curr Opinion Obstet Gynecol 16:73-78
-
(2004)
Curr Opinion Obstet Gynecol
, vol.16
, pp. 73-78
-
-
Diamanti-Kandarakis, E.1
-
36
-
-
0023857383
-
The dose-effect relationship between'unopposed' oestrogens and endometrial mitotic rate: Its central role in explaining and predicting endometrial cancer risk
-
Key TJ, Pike MC (1988) The dose-effect relationship between'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 57:205-212
-
(1988)
Br J Cancer
, vol.57
, pp. 205-212
-
-
Key, T.J.1
Pike, M.C.2
-
37
-
-
0028942126
-
A prospective study of endogenous estrogens and breast cancer in post-menopausal women
-
Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternak BS (1995) A prospective study of endogenous estrogens and breast cancer in post-menopausal women. J Natl Cancer Inst 86:1076-1082
-
(1995)
J Natl Cancer Inst
, vol.86
, pp. 1076-1082
-
-
Toniolo, P.G.1
Levitz, M.2
Zeleniuch-Jacquotte, A.3
Banerjee, S.4
Koenig, K.L.5
Shore, R.E.6
Strax, P.7
Pasternak, B.S.8
-
38
-
-
0027450031
-
Hormonal chemoprevention of cancer in women
-
Henderson BE, Ross RK, Pike MC (1993) Hormonal chemoprevention of cancer in women. Science 259:633-638
-
(1993)
Science
, vol.259
, pp. 633-638
-
-
Henderson, B.E.1
Ross, R.K.2
Pike, M.C.3
-
39
-
-
0028132860
-
Steroid hormones and risk of breast cancer
-
Hulka BS, Liu ET, Lininger RA (1993) Steroid hormones and risk of breast cancer. Cancer 74:1111-1124
-
(1993)
Cancer
, vol.74
, pp. 1111-1124
-
-
Hulka, B.S.1
Liu, E.T.2
Lininger, R.A.3
-
40
-
-
0002943172
-
Exogenous hormones and breast cancer risk
-
Neiderhuber J (ed). St. Louis, MO
-
Pike M, Bernstein L, Spicer D (1993) Exogenous hormones and breast cancer risk. In: Neiderhuber J (ed) Current Therapy in Oncol BC Decker. St. Louis, MO, pp 292-302
-
(1993)
Current Therapy in Oncol BC Decker
, pp. 292-302
-
-
Pike, M.1
Bernstein, L.2
Spicer, D.3
-
41
-
-
0034463957
-
Is estradiol a genotoxic and mutagenic carcinogen?
-
Liehr JG (2000) Is estradiol a genotoxic and mutagenic carcinogen? Endocrine Rev 21:40-54
-
(2000)
Endocrine Rev
, vol.21
, pp. 40-54
-
-
Liehr, J.G.1
-
43
-
-
0035925788
-
Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
-
Rodriguez C, Patel AV, Calle EE, Jacob EJ (2001) Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 285:1460-1465
-
(2001)
JAMA
, vol.285
, pp. 1460-1465
-
-
Rodriguez, C.1
Patel, A.V.2
Calle, E.E.3
Jacob, E.J.4
-
44
-
-
0033559179
-
Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies
-
Negri E, Tzonou A, Beral V et al (1999) Hormonal therapy for menopause and ovarian cancer in a collaborative re-analysis of European studies. Int J Cancer 80:848-85l
-
(1999)
Int J Cancer
, vol.80
-
-
Negri, E.1
Tzonou, A.2
Beral, V.3
-
45
-
-
0037125454
-
Menopausal hormone replacement therapy and risk of ovarian cancer
-
Lacey JV, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288:334-341
-
(2002)
JAMA
, vol.288
, pp. 334-341
-
-
Lacey, J.V.1
Mink, P.J.2
Lubin, J.H.3
Sherman, M.E.4
Troisi, R.5
Hartge, P.6
Schatzkin, A.7
Schairer, C.8
-
47
-
-
33749321931
-
17-beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells
-
Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH (2006) 17-beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 20:1622-1634
-
(2006)
FASEB J
, vol.20
, pp. 1622-1634
-
-
Russo, J.1
Fernandez, S.V.2
Russo, P.A.3
Fernbaugh, R.4
Sheriff, F.S.5
Lareef, H.M.6
Garber, J.7
Russo, I.H.8
-
48
-
-
0001295487
-
Mechanisms of estrogenic and antiestrogenic regulation of growth of human breast carcinoma
-
Klijn JGM (ed). Raven, New York
-
Dickson RB, Gelmann EP, Knabbe C, Jasid K, Bates S, Swain S (1987) Mechanisms of estrogenic and antiestrogenic regulation of growth of human breast carcinoma. In: Klijn JGM (ed) Hormonal manipulation of cancer: peptides, growth factors and new (anti)steroidal agents. Raven, New York, pp 381-403
-
(1987)
Hormonal Manipulation of Cancer: Peptides, Growth Factors and New (Anti)steroidal Agents
, pp. 381-403
-
-
Dickson, R.B.1
Gelmann, E.P.2
Knabbe, C.3
Jasid, K.4
Bates, S.5
Swain, S.6
-
49
-
-
0030031782
-
Estrogen receptors: Bioactivity and interactions with cell signaling pathways
-
Katzenellenbogen BS (1996) Estrogen receptors: bioactivity and interactions with cell signaling pathways. Biol Reprod 54:287-293
-
(1996)
Biol Reprod
, vol.54
, pp. 287-293
-
-
Katzenellenbogen, B.S.1
-
50
-
-
0027848672
-
DNA lesions, inducible DNA repair and cell division: Three key factors in mutagenesis and carcinogenesis
-
Ames BN, Shigenaga MK, Gold LS (1993) DNA lesions, inducible DNA repair and cell division: three key factors in mutagenesis and carcinogenesis. Environ Perspect 101:35-44
-
(1993)
Environ Perspect
, vol.101
, pp. 35-44
-
-
Ames, B.N.1
Shigenaga, M.K.2
Gold, L.S.3
-
51
-
-
0025223739
-
Estrogen carcinogenesis in hamster tissues: A critical review
-
Li JJ, Li SA (1990) Estrogen carcinogenesis in hamster tissues: a critical review. Endocr Rev 11:524-531
-
(1990)
Endocr Rev
, vol.11
, pp. 524-531
-
-
Li, J.J.1
Li, S.A.2
-
52
-
-
0018068889
-
Role of hormones in mammary neoplasia
-
Nandi S (1978) Role of hormones in mammary neoplasia. Cancer Res 38:4046-4049
-
(1978)
Cancer Res
, vol.38
, pp. 4046-4049
-
-
Nandi, S.1
-
53
-
-
0030670385
-
Dissociation between steroid receptor expression and cell proliferation in human breast
-
Clark RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in human breast. Cancer Res 57:4987-4991
-
(1997)
Cancer Res
, vol.57
, pp. 4987-4991
-
-
Clark, R.B.1
Howell, A.2
Potten, C.S.3
Anderson, E.4
-
54
-
-
0027418572
-
Microsomal hydroxylation of 2- and 4-fluorestradiol to catechol metabolites and their conversion to methyl ethers: Catechol estrogens as possible mediators of hormonal carcinogenesis
-
Ashburn SP, Han X, Liehr JG (1993) Microsomal hydroxylation of 2- and 4-fluorestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis. Mol Pharmacol 43:534-541
-
(1993)
Mol Pharmacol
, vol.43
, pp. 534-541
-
-
Ashburn, S.P.1
Han, X.2
Liehr, J.G.3
-
55
-
-
0033575072
-
Ureinary 2-hydroxyestrone/16 alphahydroxyestrone ratio and risk of breast cancer in postmenopausal women
-
Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini, Hill A, Ross RK, Pike MC (1999) Ureinary 2-hydroxyestrone/16 alphahydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 91:1067-1072
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1067-1072
-
-
Ursin, G.1
London, S.2
Stanczyk, F.Z.3
Gentzschein, E.4
Paganini Hill, A.5
Ross, R.K.6
Pike, M.C.7
-
56
-
-
84863453196
-
-
Salama SA, Kamel M, Awad M, Nasser AH, Al-Hendy A, Botting S, Arrastia C Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of Catechol-O-methyltransferase
-
Arrastia C Catecholestrogens Induce Oxidative Stress and Malignant Transformation in Human Endometrial Glandular Cells: Protective Effect of Catechol-O-methyltransferase
-
-
Salama, S.A.1
Kamel, M.2
Awad, M.3
Nasser, A.H.4
Al-Hendy, A.5
Botting, S.6
-
57
-
-
0030960009
-
Neoplastic transformation of cultured mammalian cells by estrogens and estrogen-like chemicals
-
Tsutsui T, Barrett JC (1997) Neoplastic transformation of cultured mammalian cells by estrogens and estrogen-like chemicals. Environ Health Perspect 105(suppl3):619-624
-
(1997)
Environ Health Perspect
, vol.105
, Issue.SUPPL. 3
, pp. 619-624
-
-
Tsutsui, T.1
Barrett, J.C.2
-
58
-
-
0028104962
-
Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens
-
Banerjee SK, Banerjee S, Li SA, Li JJ (1994) Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. Mutat Res 311:191-197
-
(1994)
Mutat Res
, vol.311
, pp. 191-197
-
-
Banerjee, S.K.1
Banerjee, S.2
Li, S.A.3
Li, J.J.4
-
59
-
-
0019860726
-
Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci
-
Barrett JC, Wong A, McLachlan JA (1981) Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science 212:1402-1404
-
(1981)
Science
, vol.212
, pp. 1402-1404
-
-
Barrett, J.C.1
Wong, A.2
McLachlan, J.A.3
-
60
-
-
0033018334
-
Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro
-
Mobley JA, Bhat AS, Brueggemeier RW (1999) Measurement of oxidative DNA damage by catechol estrogens and analogues in vitro. Chem Res Toxicol 12:270-277
-
(1999)
Chem Res Toxicol
, vol.12
, pp. 270-277
-
-
Mobley, J.A.1
Bhat, A.S.2
Brueggemeier, R.W.3
-
61
-
-
33746379928
-
Antioxidant protection during menstrual cycle: The effects of estradiol on ascorbic-dehydroascorbic acid plasma levels and total antioxidant plasma status in eumenorrhoic women during menstrual cycle
-
Michos C, Kiortsis DN, Evangelou A, Karkabounas S (2006) Antioxidant protection during menstrual cycle: the effects of estradiol on ascorbic-dehydroascorbic acid plasma levels and total antioxidant plasma status in eumenorrhoic women during menstrual cycle. Acta Obstet Gynecol Scand 85:960-965
-
(2006)
Acta Obstet Gynecol Scand
, vol.85
, pp. 960-965
-
-
Michos, C.1
Kiortsis, D.N.2
Evangelou, A.3
Karkabounas, S.4
-
62
-
-
77949366041
-
The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP Cohort
-
Freedman ND, Lacey JV, Hollenbeck AR, Leitzmann MF, Schatzkin A, Abnet ChC (2010) The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP Cohort. Cancer 116:1572-1581
-
(2010)
Cancer
, vol.116
, pp. 1572-1581
-
-
Freedman, N.D.1
Lacey, J.V.2
Hollenbeck, A.R.3
Leitzmann, M.F.4
Schatzkin, A.5
Abnet, Ch.C.6
-
63
-
-
31344466962
-
Hormonal and reproductive factors and the risk of bladder cancer in women
-
McGrath M, Michaud DS, De Vivo I (2006) Hormonal and reproductive factors and the risk of bladder cancer in women. Am J Epidemiol 163:236-244
-
(2006)
Am J Epidemiol
, vol.163
, pp. 236-244
-
-
McGrath, M.1
Michaud, D.S.2
De Vivo, I.3
-
64
-
-
0028582154
-
Menstrual and reproductive factors and gastriccancer in women
-
La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F, Decarli A (1994) Menstrual and reproductive factors and gastriccancer in women. Int J Cancer 59:761-764
-
(1994)
Int J Cancer
, vol.59
, pp. 761-764
-
-
La Vecchia, C.1
D'Avanzo, B.2
Franceschi, S.3
Negri, E.4
Parazzini, F.5
Decarli, A.6
-
66
-
-
78649522332
-
-
Maturitas
-
Wolpert BJ, Amr S, Ezzat S, Saleh D, Gouda I, Loay I et al (2010) Estrogen exposure and bladder cancer risk in Egyptian women. Maturitas
-
(2010)
Estrogen Exposure and Bladder Cancer Risk in Egyptian Women
-
-
Wolpert, B.J.1
Amr, S.2
Ezzat, S.3
Saleh, D.4
Gouda, I.5
Loay, I.6
-
67
-
-
25144485300
-
Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women
-
Teras LR, Patel AV, Rodriguez C, Thun MJ, Calle EE (2005) Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women. Cancer Causes and Control 16:1035-40
-
(2005)
Cancer Causes and Control
, vol.16
, pp. 1035-1040
-
-
Teras, L.R.1
Patel, A.V.2
Rodriguez, C.3
Thun, M.J.4
Calle, E.E.5
-
68
-
-
0033988203
-
Risk factors for oral and pharyngeal cancer in women: A study from Italy and Switzerland
-
Bosetti C, Negri E, Franceschi S, Conti E, Levi F, Tomei F, La Vecchia C (2000) Risk factors for oral and pharyngeal cancer in women: a study from Italy and Switzerland. Br J Cancer 82:204-207
-
(2000)
Br J Cancer
, vol.82
, pp. 204-207
-
-
Bosetti, C.1
Negri, E.2
Franceschi, S.3
Conti, E.4
Levi, F.5
Tomei, F.6
La Vecchia, C.7
-
69
-
-
67650216047
-
Estrogen deficiency as cancer risk factor
-
Chapter 5. Nova Science Publishers Inc, New York
-
Suba Zs (2009) Estrogen deficiency as cancer risk factor. Chapter 5. pp 85-106. In: Estrogen versus Cancer. Nova Science Publishers Inc, New York
-
(2009)
Estrogen Versus Cancer
, pp. 85-106
-
-
Suba, Zs.1
-
70
-
-
0141921343
-
Are smokingassociated cancers prevented or postponed in women using hormone replacement therapy?
-
Olsson H, Bladström AM, Ingvar C (2003) Are smokingassociated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 102:565-570
-
(2003)
Obstet Gynecol
, vol.102
, pp. 565-570
-
-
Olsson, H.1
Bladström, A.M.2
Ingvar, C.3
-
71
-
-
0035800491
-
Oesophageal cancer in women: Tobacco, alcohol, nutritional and hormonal factors
-
Gallus S, Bosetti C, Franceschi S, Levi F, Simonato L, Negri E, La Vecchia C (2001) Oesophageal cancer in women: tobacco, alcohol, nutritional and hormonal factors. Br J Cancer 85:341-345
-
(2001)
Br J Cancer
, vol.85
, pp. 341-345
-
-
Gallus, S.1
Bosetti, C.2
Franceschi, S.3
Levi, F.4
Simonato, L.5
Negri, E.6
La Vecchia, C.7
-
72
-
-
0030812445
-
Case-control study of estrogen replacement therapy and risk of cervical cancer
-
Parazzini F, La Vecchia C, Negri E, Franceschi S, Bolis G (1997) Case-control study of estrogen replacement therapy and risk of cervical cancer. Br Med J 315:85-88
-
(1997)
Br Med J
, vol.315
, pp. 85-88
-
-
Parazzini, F.1
La Vecchia, C.2
Negri, E.3
Franceschi, S.4
Bolis, G.5
-
73
-
-
0037717082
-
Hormone replacement therapy and cancer risk: A systematic analysis from a network of case-control studies
-
Fernandez E, Gallus S, Bosetti C, Franceschi S, Negri E, La Vecchia C (2003) Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer 105:408-412
-
(2003)
Int J Cancer
, vol.105
, pp. 408-412
-
-
Fernandez, E.1
Gallus, S.2
Bosetti, C.3
Franceschi, S.4
Negri, E.5
La Vecchia, C.6
-
74
-
-
0038187646
-
Hormonal factors and risk of lung cancer among women?
-
Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE (2003) Hormonal factors and risk of lung cancer among women? Int J Epidemiol 32:263-271
-
(2003)
Int J Epidemiol
, vol.32
, pp. 263-271
-
-
Kreuzer, M.1
Gerken, M.2
Heinrich, J.3
Kreienbrock, L.4
Wichmann, H.E.5
-
75
-
-
0141593565
-
Women's Health Initiative Investigators. Effects of estrogen plus progestin on gynaecologic cancers and associated diagnostic procedures: The Women's Health Initiative randomized trial
-
Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM (2003) Women's Health Initiative Investigators. Effects of estrogen plus progestin on gynaecologic cancers and associated diagnostic procedures: The Women's Health Initiative randomized trial. JAMA 290:1739-1748
-
(2003)
JAMA
, vol.290
, pp. 1739-1748
-
-
Anderson, G.L.1
Judd, H.L.2
Kaunitz, A.M.3
Barad, D.H.4
Beresford, S.A.5
Pettinger, M.6
Liu, J.7
McNeeley, S.G.8
Lopez, A.M.9
-
76
-
-
36749089608
-
False alarm: Postmenopausal hormone therapy and ovarian cancer
-
Schapiro S (2007) False alarm: postmenopausal hormone therapy and ovarian cancer. Climacteric 10:466-470
-
(2007)
Climacteric
, vol.10
, pp. 466-470
-
-
Schapiro, S.1
-
77
-
-
1842867053
-
Effects of conjugated equine estrogen in postmenopausal women with hysterctomy: The Women's Health Intitative randomized controlled trial
-
Women's Health Intitative Steering Committee
-
Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D et al (2004) Women's Health Intitative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterctomy: the Women's Health Intitative randomized controlled trial. JAMA 291:1701-1712
-
(2004)
JAMA
, vol.291
, pp. 1701-1712
-
-
Anderson, G.L.1
Limacher, M.2
Assaf, A.R.3
Bassford, T.4
Beresford, S.A.5
Black, H.6
Bonds, D.7
-
78
-
-
79953743574
-
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy. A randomized controlled trial
-
LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L et al (2011) Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy. A randomized controlled trial. JAMA 305:1305-1314
-
(2011)
JAMA
, vol.305
, pp. 1305-1314
-
-
Lacroix, A.Z.1
Chlebowski, R.T.2
Manson, J.E.3
Aragaki, A.K.4
Johnson, K.C.5
Martin, L.6
-
79
-
-
0034783960
-
Mechanisms of estrogen action
-
Nilsson S, Makela S, Treuter E, Tujague J, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA (2001) Mechanisms of estrogen action. Physiol Rev 81:1535-1565
-
(2001)
Physiol Rev
, vol.81
, pp. 1535-1565
-
-
Nilsson, S.1
Makela, S.2
Treuter, E.3
Tujague, J.4
Thomsen, J.5
Andersson, G.6
Enmark, E.7
Pettersson, K.8
Warner, M.9
Gustafsson, J.A.10
-
80
-
-
0033304993
-
The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
-
Hall JM, McDonnell DP (1999) The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinol 140:5566-5578
-
(1999)
Endocrinol
, vol.140
, pp. 5566-5578
-
-
Hall, J.M.1
McDonnell, D.P.2
-
81
-
-
0036780306
-
Estrogen action and cytoplasmic signaling cascades. Part I: Membrane-associated signaling complexes
-
Segars J, Driggers P (2002) Estrogen action and cytoplasmic signaling cascades. Part I: Membrane-associated signaling complexes. Trends Endocrin Metab 13:349-354
-
(2002)
Trends Endocrin Metab
, vol.13
, pp. 349-354
-
-
Segars, J.1
Driggers, P.2
-
82
-
-
27144524273
-
Estrogen receptors α (ERα) and β (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11
-
Helguero LA, Faulds MH, Gustafsson JA, Haldosen LA (2005) Estrogen receptors α (ERα) and β (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24:6605-6616
-
(2005)
Oncogene
, vol.24
, pp. 6605-6616
-
-
Helguero, L.A.1
Faulds, M.H.2
Gustafsson, J.A.3
Haldosen, L.A.4
-
83
-
-
84892116971
-
Antiestrogen or estrogen as anticancer drug
-
Ch. 4. Hoffmann AB (ed). Nova Science Publishers Inc, New York
-
Suba Zs (2011) Antiestrogen or estrogen as anticancer drug. Ch. 4. In: Hoffmann AB (ed) Sex Hormones, Development, Regulation and Disorders. Nova Science Publishers Inc, New York
-
(2011)
Sex Hormones, Development, Regulation and Disorders
-
-
Suba, Zs.1
-
84
-
-
0001548401
-
Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: Studies of ERα and ERβ expressed in Chinese hamster ovary cells
-
Razandi M, Pedram A, Greene GL, Levin ER (1999) Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319
-
(1999)
Mol Endocrinol
, vol.13
, pp. 307-319
-
-
Razandi, M.1
Pedram, A.2
Greene, G.L.3
Levin, E.R.4
-
85
-
-
0038407651
-
Estrogen action and cytoplasmic signaling pathways. Part II: The role of growth factors and phosphorylation in estrogen signaling
-
Driggers PH, Segars JH (2002) Estrogen action and cytoplasmic signaling pathways. Part II: The role of growth factors and phosphorylation in estrogen signaling. Trends Endocrin Metab 13:422-427
-
(2002)
Trends Endocrin Metab
, vol.13
, pp. 422-427
-
-
Driggers, P.H.1
Segars, J.H.2
-
86
-
-
0028886694
-
Activation of the estrogen receptor though phosphorylation by mitogen-activated protein kinase
-
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P (1995) Activation of the estrogen receptor though phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
-
(1995)
Science
, vol.270
, pp. 1491-1494
-
-
Kato, S.1
Endoh, H.2
Masuhiro, Y.3
Kitamoto, T.4
Uchiyama, S.5
Sasaki, H.6
Masushige, S.7
Gotoh, Y.8
Nishida, E.9
Kawashima, H.10
Metzger, D.11
Chambon, P.12
-
87
-
-
0034866694
-
Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways
-
Lundholt BK, Briand P, Lykkesfeldt AE (2001) Growth inhibition and growth stimulation by estradiol of estrogen receptor transfected human breast epithelial cell lines involve different pathways. Breast Cancer Res Treat 67:199-214
-
(2001)
Breast Cancer Res Treat
, vol.67
, pp. 199-214
-
-
Lundholt, B.K.1
Briand, P.2
Lykkesfeldt, A.E.3
-
88
-
-
33846869263
-
Resistance to endocrine therapy in breast cancer: Exploiting estrogen receptor/growth factor crosstalk
-
Massarweh S, Schiff R (2006) Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor crosstalk. Endocrin-Related Cancer Suppl 13(1):S15-24
-
(2006)
Endocrin-Related Cancer Suppl
, vol.13
, Issue.1
-
-
Massarweh, S.1
Schiff, R.2
-
89
-
-
33847055890
-
Estrogen receptor signaling pathways in human non-small cell lung cancer
-
Marquez-Garban DC, Chen HW, Fishbein MC, Goodglick L, Pietras RJ (2007) Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 72:135-143
-
(2007)
Steroids
, vol.72
, pp. 135-143
-
-
Marquez-Garban, D.C.1
Chen, H.W.2
Fishbein, M.C.3
Goodglick, L.4
Pietras, R.J.5
-
90
-
-
0026086048
-
Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation
-
Nelson KG, Takahashi T, Bossert NL, Walmer DK, McLachlan JA (1991) Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proceed Natl Acad Sci USA 88:21-25
-
(1991)
Proceed Natl Acad Sci USA
, vol.88
, pp. 21-25
-
-
Nelson, K.G.1
Takahashi, T.2
Bossert, N.L.3
Walmer, D.K.4
McLachlan, J.A.5
-
91
-
-
0029985147
-
Physiological coupling of growth factor and steroid receptor signaling pathway: Estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor
-
Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, Korach KS (1996) Physiological coupling of growth factor and steroid receptor signaling pathway: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proceed Natl Acad Sci USA 93:12626-12630
-
(1996)
Proceed Natl Acad Sci USA
, vol.93
, pp. 12626-12630
-
-
Curtis, S.W.1
Washburn, T.2
Sewall, C.3
Diaugustine, R.4
Lindzey, J.5
Couse, J.F.6
Korach, K.S.7
-
93
-
-
26844582510
-
Estrogen and exercise may enhance β-cell function and mass via insulin receptor substrate 2 induction in ovarectomized diabetic rats
-
Choi SB, Jang JS, Park S (2005) Estrogen and exercise may enhance β-cell function and mass via insulin receptor substrate 2 induction in ovarectomized diabetic rats. Endocrinology 146:4786-4794
-
(2005)
Endocrinology
, vol.146
, pp. 4786-4794
-
-
Choi, S.B.1
Jang, J.S.2
Park, S.3
-
94
-
-
33244495940
-
Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: Insulin sensitivity in the liver
-
Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL et al (2006) Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49:588-597
-
(2006)
Diabetologia
, vol.49
, pp. 588-597
-
-
Bryzgalova, G.1
Gao, H.2
Ahren, B.3
Zierath, J.R.4
Galuska, D.5
Steiler, T.L.6
-
95
-
-
0033304699
-
Regulation of glucose transporters by estradiol in the immature rat uterus
-
Welch RD, Gorski J (1999) Regulation of glucose transporters by estradiol in the immature rat uterus. Endocrinology 140:3602-3608
-
(1999)
Endocrinology
, vol.140
, pp. 3602-3608
-
-
Welch, R.D.1
Gorski, J.2
-
96
-
-
0002377198
-
Impact of menopause on metabolism
-
Diamond MP, Naftolin K (eds). Ares Seerono Symposia, Rome
-
Godsland IF, Walton C, Stevenson JC (1993) Impact of menopause on metabolism. In: Diamond MP, Naftolin K (eds) Metabolism in the female life cycle. Ares Seerono Symposia, Rome, pp 171-189
-
(1993)
Metabolism in the Female Life Cycle
, pp. 171-189
-
-
Godsland, I.F.1
Walton, C.2
Stevenson, J.C.3
-
97
-
-
12944276957
-
Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity
-
Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:12735-12740
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 12735-12740
-
-
Jones, M.E.1
Thorburn, A.W.2
Britt, K.L.3
Hewitt, K.N.4
Wreford, N.G.5
Proietto, J.6
Oz, O.K.7
Leury, B.J.8
Robertson, K.M.9
Yao, S.10
Simpson, E.R.11
-
98
-
-
33846027512
-
Estrogen receptor alpha regulates insulin sensitivity trough IRS-1 thyrosin phosphorylation in mature 3 T3-L1 adipocytes
-
Muraki K, Okuya S, Tanizawa Y (2006) Estrogen receptor alpha regulates insulin sensitivity trough IRS-1 thyrosin phosphorylation in mature 3 T3-L1 adipocytes. Endocr J 53:841-851
-
(2006)
Endocr J
, vol.53
, pp. 841-851
-
-
Muraki, K.1
Okuya, S.2
Tanizawa, Y.3
-
99
-
-
0030741639
-
17β-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier
-
Shi J, Simpkins JW (1997) 17β-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Physiol 272:1016-1022
-
(1997)
Am J Physiol
, vol.272
, pp. 1016-1022
-
-
Shi, J.1
Simpkins, J.W.2
-
100
-
-
0027450302
-
Insulin resistance in polycystic ovary syndrome: Decreased expression of GLUT-4 glucose transporters in adipocytes
-
Rosenbaum D, Haber RS, Dunaif A (1993) Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am J Physiol 264:197-202
-
(1993)
Am J Physiol
, vol.264
, pp. 197-202
-
-
Rosenbaum, D.1
Haber, R.S.2
Dunaif, A.3
-
101
-
-
30944442454
-
Altered subcellular distribution of estrogen receptor is implicated in estradiolinduced dual regulation of insulin signaling in 3 T3-L1 adipocytes
-
Nagira K, Sasaoka T, Wada T, Fukui K, Ikubo M, Hori S, Tsuneki H, Saito S, Kobayashi M (2006) Altered subcellular distribution of estrogen receptor is implicated in estradiolinduced dual regulation of insulin signaling in 3 T3-L1 adipocytes. Endocrinology 147:1020-1028
-
(2006)
Endocrinology
, vol.147
, pp. 1020-1028
-
-
Nagira, K.1
Sasaoka, T.2
Wada, T.3
Fukui, K.4
Ikubo, M.5
Hori, S.6
Tsuneki, H.7
Saito, S.8
Kobayashi, M.9
-
103
-
-
0026072558
-
Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
-
Walsh BW, Schiff I, Rosner B, Greenberg L, Ravinkar V, Sacks FM (1991) Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New England J Med 325:1196-1204
-
(1991)
New England J Med
, vol.325
, pp. 1196-1204
-
-
Walsh, B.W.1
Schiff, I.2
Rosner, B.3
Greenberg, L.4
Ravinkar, V.5
Sacks, F.M.6
-
104
-
-
39049173131
-
Protective effect of 17beta-estradiol on oxidative stress and liver dysfunction in aged male rats
-
Hamden K, Carreau S, Ellouz F, Masmoudi H, El FA (2007) Protective effect of 17beta-estradiol on oxidative stress and liver dysfunction in aged male rats. J Physiol Biochem 63:195-201
-
(2007)
J Physiol Biochem
, vol.63
, pp. 195-201
-
-
Hamden, K.1
Carreau, S.2
Ellouz, F.3
Masmoudi, H.4
El, F.A.5
-
105
-
-
0030857452
-
Androgen receptor-mediated antagonism of estrogendependent low density lipoprotein receptor transcription in cultured hepatocytes
-
Croston GE, Milan LB, Marschke KB, Reichman M, Briggs MR (1997) Androgen receptor-mediated antagonism of estrogendependent low density lipoprotein receptor transcription in cultured hepatocytes. Endocrinology 138:3779-3786
-
(1997)
Endocrinology
, vol.138
, pp. 3779-3786
-
-
Croston, G.E.1
Milan, L.B.2
Marschke, K.B.3
Reichman, M.4
Briggs, M.R.5
-
106
-
-
43749119425
-
Estrogen regulation of adipose tissue functions: Involvement of estrogen receptor isoforms
-
Pallottini V, Bulzomi P, Galluzzo P, Martini C, Marino M (2008) Estrogen regulation of adipose tissue functions: Involvement of estrogen receptor isoforms. Infectious Disorders - Drug Targets 8:52-60
-
(2008)
Infectious Disorders - Drug Targets
, vol.8
, pp. 52-60
-
-
Pallottini, V.1
Bulzomi, P.2
Galluzzo, P.3
Martini, C.4
Marino, M.5
-
107
-
-
64649104155
-
Sex and depot differences in adipocyte insulin sensitivity and glucose
-
Macotela Y, Boucher J, Tran TT, Kahn CR (2009) Sex and depot differences in adipocyte insulin sensitivity and glucose. Diabetes 58:803-812
-
(2009)
Diabetes
, vol.58
, pp. 803-812
-
-
MacOtela, Y.1
Boucher, J.2
Tran, T.T.3
Kahn, C.R.4
-
108
-
-
0028882708
-
Changes in energy balance and body composition at menopause
-
Poehlman ET, Toth MJ, Gardner AW (1995) Changes in energy balance and body composition at menopause. Ann Intern Med 123:673-675
-
(1995)
Ann Intern Med
, vol.123
, pp. 673-675
-
-
Poehlman, E.T.1
Toth, M.J.2
Gardner, A.W.3
-
109
-
-
84856105507
-
Correlations between obesity and risk for salivary gland tumors
-
Suba Z (2009) Correlations between obesity and risk for salivary gland tumors. Cancer Res J 3:55-68
-
(2009)
Cancer Res J
, vol.3
, pp. 55-68
-
-
Suba, Z.1
-
110
-
-
3543072186
-
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
-
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579-591
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 579-591
-
-
Calle, E.E.1
Kaaks, R.2
-
111
-
-
0142186758
-
The CYP19 gene and association with androgens and abdominal obesity in premenopausal women
-
Baghaei F, Rosmond R, Westberg L, Hellstrand M, Eriksson E, Holm G, Björntorp P (2003) The CYP19 gene and association with androgens and abdominal obesity in premenopausal women. Obesity Res 11:578-585
-
(2003)
Obesity Res
, vol.11
, pp. 578-585
-
-
Baghaei, F.1
Rosmond, R.2
Westberg, L.3
Hellstrand, M.4
Eriksson, E.5
Holm, G.6
Björntorp, P.7
-
112
-
-
0029972402
-
The regulation of adipose tissue distribution in humans
-
Björntorp P (1996) The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 20:291-302
-
(1996)
Int J Obes Relat Metab Disord
, vol.20
, pp. 291-302
-
-
Björntorp, P.1
-
113
-
-
29244490639
-
Polycystic ovarian syndrome and the metabolic syndrome
-
Sartor BM, Dickey RP (2005) Polycystic ovarian syndrome and the metabolic syndrome. Am J Med 330:336-342
-
(2005)
Am J Med
, vol.330
, pp. 336-342
-
-
Sartor, B.M.1
Dickey, R.P.2
-
114
-
-
0023772227
-
Insulin-like growth factor i and insulin potentiate luteinizing hormone induced androgen synthesis by rat ovarian thecal-interstitial cells
-
Cara JF, Rosenfield RL (1988) Insulin-like growth factor I and insulin potentiate luteinizing hormone induced androgen synthesis by rat ovarian thecal-interstitial cells. Endrocrinology 123:733-739
-
(1988)
Endrocrinology
, vol.123
, pp. 733-739
-
-
Cara, J.F.1
Rosenfield, R.L.2
-
115
-
-
0034892698
-
Metformin directly inhibits androgen production in human thecal cells
-
Attia GR, Rainey WE, Carr BR (2001) Metformin directly inhibits androgen production in human thecal cells. Fertil Steril 76:517-524
-
(2001)
Fertil Steril
, vol.76
, pp. 517-524
-
-
Attia, G.R.1
Rainey, W.E.2
Carr, B.R.3
-
116
-
-
0029927833
-
Insulin infusion amplifies 17-(alpha)-hydroxy-corticosteroid intermediates response to adrenocorticotropin in hyperandrogenicwomen: Apparent relative impairment of 17,20-lyase activity
-
Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, Balducci R, Toscano V, Muggeo M (1996) Insulin infusion amplifies 17-(alpha)-hydroxy- corticosteroid intermediates response to adrenocorticotropin in hyperandrogenicwomen: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 81:881-886
-
(1996)
J Clin Endocrinol Metab
, vol.81
, pp. 881-886
-
-
Moghetti, P.1
Castello, R.2
Negri, C.3
Tosi, F.4
Spiazzi, G.G.5
Brun, E.6
Balducci, R.7
Toscano, V.8
Muggeo, M.9
-
117
-
-
59349107509
-
Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome
-
Christakou C, Diamanti-Kandarakis E (2008) Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Women's Health 4:583-594
-
(2008)
Women's Health
, vol.4
, pp. 583-594
-
-
Christakou, C.1
Diamanti-Kandarakis, E.2
-
118
-
-
0035930060
-
Long or highly irregular menstrual cycles as a marker for risk of type-2 diabetes mellitus
-
Solomon CG, Hu FB, Dunaif A, Rich-Edwards J, Willett WC, Hunter DJ, Colditz GA, Speizer FE, Manson JE (2001) Long or highly irregular menstrual cycles as a marker for risk of type-2 diabetes mellitus. JAMA 286:2421-2426
-
(2001)
JAMA
, vol.286
, pp. 2421-2426
-
-
Solomon, C.G.1
Hu, F.B.2
Dunaif, A.3
Rich-Edwards, J.4
Willett, W.C.5
Hunter, D.J.6
Colditz, G.A.7
Speizer, F.E.8
Manson, J.E.9
-
119
-
-
0035109106
-
Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population
-
Elting MW, Dorsen TJM, Bezemer PD, Schoemaker J (2001) Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population. Hum Reprod 16:556-560
-
(2001)
Hum Reprod
, vol.16
, pp. 556-560
-
-
Elting, M.W.1
Tjm, D.2
Bezemer, P.D.3
Schoemaker, J.4
-
120
-
-
20844462886
-
Polycystic ovary syndrome and gynecological cancers: Is there a link?
-
Gadducci A, Gargini A, Palla E, Fanucchi A, Genazzani AR (2005) Polycystic ovary syndrome and gynecological cancers: is there a link? Gynecol Endocrinol 20:200-208
-
(2005)
Gynecol Endocrinol
, vol.20
, pp. 200-208
-
-
Gadducci, A.1
Gargini, A.2
Palla, E.3
Fanucchi, A.4
Genazzani, A.R.5
-
121
-
-
2042548063
-
Mortality of women with polycystic ovary syndrome at long-term follow-up
-
Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS (1998) Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-586
-
(1998)
J Clin Epidemiol
, vol.51
, pp. 581-586
-
-
Pierpoint, T.1
McKeigue, P.M.2
Isaacs, A.J.3
Wild, S.H.4
Jacobs, H.S.5
-
122
-
-
0027532914
-
WHO Ad Hoc Diabetes Reporting Group: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults
-
King H, Rewers M (1993) WHO Ad Hoc Diabetes Reporting Group: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 21:157-177
-
(1993)
Diabetes Care
, vol.21
, pp. 157-177
-
-
King, H.1
Rewers, M.2
-
123
-
-
0032184908
-
Does estrogen reduce glycemic levels?
-
Wilson PWE (1998) Does estrogen reduce glycemic levels? Diabetes Care 21:1585-1586
-
(1998)
Diabetes Care
, vol.21
, pp. 1585-1586
-
-
Pwe, W.1
-
124
-
-
0642279570
-
Insulin, insulin-like growth factor-1 and breast cancer risk in Japanese women
-
Hirose K, Toyama T, Iwata H, Takezaki T, Hamajima N, Tajima K (2003) Insulin, insulin-like growth factor-1 and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 4:239-246
-
(2003)
Asian Pac J Cancer Prev
, vol.4
, pp. 239-246
-
-
Hirose, K.1
Toyama, T.2
Iwata, H.3
Takezaki, T.4
Hamajima, N.5
Tajima, K.6
-
125
-
-
0030890802
-
Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk
-
Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A, Redwood S, Hood N, DelGiudice ME, Sidlofsky S, McGready D, Wilkinson R, Mahoney L, Connelly P, Page DL (1997) Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 27:284-292
-
(1997)
Nutr Cancer
, vol.27
, pp. 284-292
-
-
Goodwin, P.J.1
Boyd, N.F.2
Hanna, W.3
Hartwick, W.4
Murray, D.5
Qizilbash, A.6
Redwood, S.7
Hood, N.8
Delgiudice, M.E.9
Sidlofsky, S.10
McGready, D.11
Wilkinson, R.12
Mahoney, L.13
Connelly, P.14
Page, D.L.15
-
126
-
-
27744532581
-
Oestrogens and insulin secretion
-
Godsland IF (2005) Oestrogens and insulin secretion. Diabetologia 48:2213-2220
-
(2005)
Diabetologia
, vol.48
, pp. 2213-2220
-
-
Godsland, I.F.1
-
127
-
-
0026655766
-
Aging and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women
-
Proudler AJ, Felton CV, Stevenson JC (1992) Aging and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women. Clin Sci 83:489-494
-
(1992)
Clin Sci
, vol.83
, pp. 489-494
-
-
Proudler, A.J.1
Felton, C.V.2
Stevenson, J.C.3
-
128
-
-
0034537163
-
Coronary artery disease: Is menopause a risk factor?
-
Gohlke-Barwolf C (2000) Coronary artery disease: is menopause a risk factor? Basic Res Cardiol 95:177-183
-
(2000)
Basic Res Cardiol
, vol.95
, pp. 177-183
-
-
Gohlke-Barwolf, C.1
-
129
-
-
33646404099
-
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria
-
Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2006) Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 49:945-952
-
(2006)
Diabetologia
, vol.49
, pp. 945-952
-
-
Rapp, K.1
Schroeder, J.2
Klenk, J.3
Ulmer, H.4
Concin, H.5
Diem, G.6
Oberaigner, W.7
Weiland, S.K.8
-
130
-
-
0036798987
-
Obesity, body size and risk of postmenopausal breast cancer: The Women's Health Initiative (United States)
-
Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A (2002) Obesity, body size and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 13:741-751
-
(2002)
Cancer Causes Control
, vol.13
, pp. 741-751
-
-
Morimoto, L.M.1
White, E.2
Chen, Z.3
Chlebowski, R.T.4
Hays, J.5
Lopez, A.M.6
Manson, J.7
Margolis, K.L.8
Muti, P.C.9
Stefanick, M.L.10
McTiernan, A.11
-
131
-
-
38849165858
-
Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype
-
McCullough ML, Patel AV, Patel R, Rodriguez C, Feigelson HS, Bandera EV, Gansler T (2008) Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomark Prev 17:73-79
-
(2008)
Cancer Epidemiol Biomark Prev
, vol.17
, pp. 73-79
-
-
McCullough, M.L.1
Patel, A.V.2
Patel, R.3
Rodriguez, C.4
Feigelson, H.S.5
Bandera, E.V.6
Gansler, T.7
-
132
-
-
79958064654
-
Decreased oral cancer risk by moderate alcohol consumption in non-smoker postmenopausal women
-
Takács D, Koppány F, Mihályi S, Suba Z (2011) Decreased oral cancer risk by moderate alcohol consumption in non-smoker postmenopausal women. Oral Oncol 47:537-540
-
(2011)
Oral Oncol
, vol.47
, pp. 537-540
-
-
Takács, D.1
Koppány, F.2
Mihályi, S.3
Suba, Z.4
|